Insider · CIK 0001745958
Davis Jerel
Files at TSBX (Turnstone Biologics Corp.). First filing -, latest -.
In brief
Davis Jerel files SEC Form 4 as director at TSBX (Turnstone Biologics Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Davis Jerel has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | UTender of shares Common Stockindirect: By Versant Vantage II, L.P. | -274,990 | - | - | 0 | Aug 8, 2025 |
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | UTender of shares Common Stockindirect: By Versant Venture Capital V, L.P. | -2,726,322 | - | - | 0 | Aug 8, 2025 |
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | UTender of shares Common Stockindirect: By Versant Venture Capital V (Canada) LP | -207,486 | - | - | 0 | Aug 8, 2025 |
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | UTender of shares Common Stockindirect: By Versant Ophthalmic Affiliates Fund I, L.P. | -90,888 | - | - | 0 | Aug 8, 2025 |
| Aug 8, 2025 | TSBX Turnstone Biologics Corp. | UTender of shares Common Stockindirect: By Versant Affiliates Fund V, L.P. | -82,006 | - | - | 0 | Aug 8, 2025 |
Questions about Davis Jerel
Answered from the filings on this page, as of the latest one.
Is Davis Jerel buying or selling?
Davis Jerel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Davis Jerel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Davis Jerel has 0.
Where does Davis Jerel file Form 4?
Davis Jerel has filed Form 4 at TSBX (Turnstone Biologics Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.